Crossmark

Unsupervised correction of gene-independent cell responses to CRISPR-Cas9 targeting

Crossref DOI link: https://doi.org/10.1186/s12864-018-4989-y

Published Online: 2018-08-13

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Iorio, Francesco

Behan, Fiona M.

Gonçalves, Emanuel

Bhosle, Shriram G.

Chen, Elisabeth

Shepherd, Rebecca

Beaver, Charlotte

Ansari, Rizwan

Pooley, Rachel

Wilkinson, Piers

Harper, Sarah

Butler, Adam P.

Stronach, Euan A.

Saez-Rodriguez, Julio

Yusa, Kosuke

Garnett, Mathew J.
Funding

Funding for this research was provided by:

Open Targets (015)

Cancer Research UK (C44943/A22536, SU2C-AACR-DT1213)

Wellcome Trust (GB) (102696)
License Information

Text and Data Mining valid from 2018-08-13
More Information

Article History

Received: 21 January 2018

Accepted: 31 July 2018

First Online: 13 August 2018

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: E.A.S. is an employee of GlaxoSmithKline.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.